GPCR Structure Therapeutics Inc. Loading... : Bullish and Bearish Analyst Opinions
Loading chart...
Top Calls
Feed
12:53
Aug 17
Aug 17
Reports widest ownership across specialist funds
"Reports widest Q2 2026 ownership across 95 specialist funds based on 13F filings, no directional view."
MED
12:50
Aug 17
Aug 17
Reports most reduced positions across funds
"Reports most reduced positions across specialist funds in Q2 2026 excluding M&A take-outs, no directional view."
MED
11:58
Aug 17
Aug 17
Reports widest Q2 ownership among specialist funds
Reports the widest Q2 2026 ownership across 93 specialist funds based on 13F filings.
MED
13:13
Jun 21
Jun 21
Buy the "hot zone" biotech names (3–9 months post positive data) as the author's historical M&A.
Buy the "hot zone" biotech names (3–9 months post positive data) as the author's historical M&A timing framework shows this is the window where acquirers with pre-committed capital execute; sector M&A wave across radiopharmaceuticals, MASH, IBD, and obesity validates the pattern is active.
MED
00:55
Jun 21
Jun 21
The tweet maps biotech M&A timing and independent name catalysts since the XBI bottom.
The tweet maps biotech M&A timing and independent name catalysts since the XBI bottom, but it is a factual research summary without explicit author positions or forward calls.
LOW
14:10
Mar 16
Mar 16
The company's new drug data suggests it could become a viable competitor in the lucrative.
The company's new drug data suggests it could become a viable competitor in the lucrative weight-loss market, creating a fundamental catalyst for upside.
MED
00:00
Feb 24
Feb 24
Speaker argues NVO is unlikely to acquire GPCR because doing so would undermine NVO's narrative.
Speaker argues NVO is unlikely to acquire GPCR because doing so would undermine NVO's narrative around oral sema's clinical superiority over orforglipron.
MED
About GPCR Analyst Coverage
Buzzberg tracks GPCR (Structure Therapeutics Inc.) across 3 sources. 1 bullish vs 0 bearish calls from 3 analysts. Sentiment: predominantly bullish (14%). 7 total trade ideas tracked. Latest voices: seedy19tron, business, A May MD.